Jennifer Adair to Combined Modality Therapy
This is a "connection" page, showing publications Jennifer Adair has written about Combined Modality Therapy.
Connection Strength
0.247
-
Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP. Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Invest. 2014 Sep; 124(9):4082-92.
Score: 0.109
-
Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, Mrugala MM, Kiem HP. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med. 2012 May 09; 4(133):133ra57.
Score: 0.093
-
Mrugala MM, Adair JE, Kiem HP. Outside the box--novel therapeutic strategies for glioblastoma. Cancer J. 2012 Jan-Feb; 18(1):51-8.
Score: 0.023
-
Watts KL, Adair J, Kiem HP. Hematopoietic stem cell expansion and gene therapy. Cytotherapy. 2011 Nov; 13(10):1164-71.
Score: 0.022